Factors such as rising prevalence of chronic diseases, growth in the biologics market, funding initiatives for drug delivery research, and technological advancements are driving the growth of this market.
The North American Drug Delivery Technologies Market is
projected to reach USD 758.7 Billion by 2021 from USD 520.0 Billion in 2016, at
a CAGR of 6.5%.
Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1209
In this report, the North American drug
delivery technologies market is segmented on the basis of route of
administration, end user, and region. Based on end user, the market is
segmented into hospitals, ambulatory surgical centers (ASCs)/clinics, home care
settings, and other end users. The home care settings segment is expected to
register the highest CAGR during the forecast period. Improving patient
acceptability, patient awareness, and the need for comfortable usability have
increased the use of drug delivery systems in home care settings, thus
contributing to the growth of this end-user segment.
Based on route of administration, the North
American drug delivery technologies market is segmented into oral, pulmonary,
injectable, ocular, nasal, topical, implantable, and transmucosal drug
delivery. The topical drug delivery market is expected to grow at the highest
CAGR during the forecast period.
The North American drug delivery
technologies market is divided into two country-level segments, namely, the
U.S. and Canada. The U.S. is expected to continue to dominate the market during
the forecast period.
Speak To Analyst: - https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=1209
Johnson & Johnson, Inc. (U.S.),
Novartis AG (Switzerland), F. Hoffman-La-Roche Ltd. (Switzerland), Bayer AG
(Germany), Pfizer, Inc. (U.S.), 3M Company (U.S.), Becton, Dickinson and
Company (U.S.), Merck & Co, Inc. (U.S.), Sanofi (France), Antares Pharma,
Inc. (U.S.), and GlaxoSmithKline Plc. (U.K.) are some of the prominent players
in the North American drug delivery technologies market.
No comments:
Post a Comment